Emotion constructs and outcome measures following false positive breast screening test results: A systematic review of reporting clarity and selection rationale

Abstract

AbstractObjective(i) To systematically identify constructs and outcome measures used to assess the emotional and mood impact of false positive breast screening test results; (ii) to appraise the reporting clarity and rationale for selecting constructs and outcome measures.MethodsDatabases (MEDLINE, CINAHL, PsycINFO) were systematically searched from 1970. Studies using standardised and non‐standardised outcome measures to evaluate the emotion or mood impact of false positive breast screening test results were eligible. A 15‐item coding scheme was devised to appraise articles on clarity and rationale for selected constructs and measures.ResultsForty‐seven articles were identified. The most investigated constructs were general anxiety and depression and disease‐specific anxiety and worry. Twenty‐two standardised general outcome questionnaire measures and three standardised disease‐specific outcome questionnaire measures were identified. Twenty articles used non‐standardised scales/items. Reporting of constructs and outcome measures was generally clear, but rationales for their selection were lacking. Anxiety was typically justified, but justification for depression was almost always absent. Practical and psychometric justification for selecting outcome measures was lacking, and theoretical rationale was absent.ConclusionsHeterogeneity in constructs and measures, coupled with unclear rationale for these, impedes a thorough understanding of why there are emotional effects of false positive screening test results. This may explain the repeated practice of investigating less relevant outcomes such as depression. There is need to develop a consensual conceptual model of and standardised approach to measuring emotional impact from cancer screening test results, to address heterogeneity and other known issues of interpreting an inconsistent evidence base.